Atlas Trials

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Clinical trial NCT02944357 · WITHDRAWN

Trial details

NCT number
NCT02944357
Sponsor
Mayo Clinic
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial CarcinomaStage IV Bladder Urothelial Carcinoma
Start date
2016-11-01
Primary completion
2017-09-05
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.